Waycross Partners LLC raised its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 104.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,638 shares of the conglomerate’s stock after purchasing an additional 3,388 shares during the quarter. Waycross Partners LLC’s holdings in Danaher were worth $1,471,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. BlackRock Inc. bought a new stake in shares of Danaher during the 2nd quarter worth $10,492,520,000. Wellington Management Group LLP grew its position in Danaher by 10.4% in the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after acquiring an additional 1,542,310 shares during the last quarter. Jupiter Topco LLC bought a new position in Danaher in the second quarter valued at about $1,456,317,000. Generation Investment Management LLP acquired a new position in Danaher during the second quarter worth about $1,287,949,000. Finally, Bank of America Corp DE acquired a new position in Danaher during the second quarter worth about $993,846,000. Institutional investors own 79.05% of the company’s stock.
Insider Buying and Selling at Danaher
In related news, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total value of $1,782,186.88. Following the completion of the sale, the chief accounting officer directly owned 9,107 shares in the company, valued at $2,136,137.92. This represents a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 10.80% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on the stock. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research note on Monday, October 26th. Wells Fargo & Company lowered their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Stifel Nicolaus upped their price objective on shares of Danaher from $220.00 to $260.00 and gave the stock a “buy” rating in a research report on Thursday, October 22nd. Royal Bank Of Canada increased their price objective on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research note on Monday, October 5th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $242.91.
Read Our Latest Research Report on DHR
Danaher Trading Up 1.8%
Shares of NYSE:DHR traded up $4.00 during midday trading on Friday, hitting $230.34. 4,061,059 shares of the stock were exchanged, compared to its average volume of 4,502,111. The business’s 50-day moving average price is $220.27 and its 200 day moving average price is $201.60. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63. The stock has a market capitalization of $162.05 billion, a price-to-earnings ratio of 37.70, a P/E/G ratio of 2.86 and a beta of 0.76.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The business had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. During the same period last year, the company earned $1.89 EPS. The firm’s revenue was up 8.3% compared to the same quarter last year. Analysts predict that Danaher Corporation will post 8.59 earnings per share for the current year.
Danaher Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 30th. Danaher’s payout ratio is 26.19%.
About Danaher
Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing.
The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.
Further Reading
- Five stocks we like better than Danaher
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
